Skip to main content
COPL
NYSE Real Estate & Construction

Copley Sets Oct 29 Vote on 12-Month Extension After Ignite Deal Collapse

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Financial
Sentiment info
Neutral
Importance info
7
Price
$10.59
Mkt Cap
$191.948M
52W Low
$9.98
52W High
$10.69
52W Position info
6.1% above low
Off High info
at 52W high
Rel. Volume
Market data snapshot near publication time

COPL is trading near its 52-week low of $9.98 (6.1% above the low).

Summary

Copley is asking shareholders on October 29 to approve up to 12 monthly extensions to November 2, 2027, funded by $150,000 per month from the sponsor, after its Ignite Proteomics deal fell apart. Without approval the SPAC liquidates at about $10.61 per share and warrants expire worthless.


Key Events · Corporate Governance and Compliance · COPL

  • Shareholder Vote Set for October 29

    An extraordinary general meeting on October 29, 2026 asks holders to approve a charter amendment allowing up to 12 one-month extensions from November 2, 2026 to November 2, 2027, plus a matching trust agreement amendment and an adjournment proposal.

  • Sponsor Funds $150,000 Per Month

    Each monthly extension requires a $150,000 deposit into the trust, up to $1.8M over 12 months, repaid via non-interest-bearing unsecured promissory notes only if a business combination closes; the sponsor is not obligated to fund any extension.

  • Redemption at About $10.61 Per Share

    The trust holds approximately $183,019,397.31 across 17,250,000 Public Shares, a redemption price of about $10.61 versus the $10.59 close on the October 19 record date; election deadline is 5:00 p.m. Eastern on October 27, 2026.

  • 55.15% of Public Shares Needed

    The Extension and Trust Agreement proposals each need two-thirds of votes cast, which works out to 9,513,036 Public Shares (55.15%) if all shares are represented; the sponsor's 5,750,000 founder shares and 555,893 private shares (26.57%) are voted in favor.


Analysis · COPL · Real Estate & Construction

With the Ignite Proteomics deal mutually terminated on October 13, Copley has no business combination left to close and its termination date is November 2, 2026. This proxy asks shareholders to approve up to twelve monthly extensions to November 2, 2027, funded by $150,000 per month from the sponsor into the trust (up to $1.8M total) in exchange for non-interest-bearing promissory notes. The vote is the difference between the company continuing to search for a target and liquidating in roughly two weeks. Approval needs 55.15% of Public Shares, a high bar for a SPAC with a collapsed deal, and holders can instead redeem at about $10.61 per share versus the $10.59 close on the record date. If the extension fails, the trust is wound up and the warrants expire worthless.

How filings like this one have moved

In the 30 days to Oct 20, 2026, 29.2% of the 1466 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.57%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, COPL was trading at $10.59 on NYSE in the Real Estate & Construction sector, with a market capitalization of approximately $191.9M. The 52-week trading range was $9.98 to $10.69. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

COPL - Latest Insights

COPL
Oct 13, 2026, 5:00 PM EDT
Filing Type: 8-K
Importance Score:
8
COPL
Sep 29, 2026, 5:21 PM EDT
Filing Type: PRE 14A
Importance Score:
8
COPL
Jun 11, 2026, 6:02 AM EDT
Source: Reuters
Importance Score:
9
COPL
Jun 11, 2026, 6:00 AM EDT
Filing Type: 8-K
Importance Score:
9
COPL
May 20, 2026, 5:00 PM EDT
Filing Type: 10-Q
Importance Score:
9